Morgan Stanley
STTK icon

Morgan Stanley’s Shattuck Labs STTK Stock Holding History

Morgan Stanley’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.29M Buy
200,136
+182,028
+1,005% +$863K ﹤0.01% 5019
2025
Q4 		$66.1K Buy
18,108
+1,457
+9% +$3.48K ﹤0.01% 6349
2025
Q3 		$39.8K Sell
16,651
-7,437
-31% -$9.1K ﹤0.01% 6478
2025
Q2 		$19.1K Sell
24,088
-56,291
-70% -$54.6K ﹤0.01% 6662
2025
Q1 		$76.4K Sell
80,379
-197,551
-71% -$243K ﹤0.01% 6130
2024
Q4 		$336K Buy
277,930
+321
+0.1% +$398 ﹤0.01% 5580
2024
Q3 		$969K Buy
277,609
+57,816
+26% +$216K ﹤0.01% 5061
2024
Q2 		$848K Buy
219,793
+117,799
+115% +$958K ﹤0.01% 5058
2024
Q1 		$912K Buy
101,994
+80,224
+369% +$735K ﹤0.01% 5004
2023
Q4 		$155K Buy
21,770
+18,694
+608% +$51K ﹤0.01% 6038
2023
Q3 		$4.68K Hold
3,076
– – ﹤0.01% 6929
2023
Q2 		$9.6K Sell
3,076
-21,839
-88% -$63.4K ﹤0.01% 6827
2023
Q1 		$73.3K Buy
24,915
+21,412
+611% +$75.7K ﹤0.01% 6130
2022
Q4 		$8.06K Sell
3,503
-512,467
-99% -$1.28M ﹤0.01% 7010
2022
Q3 		$1.39M Sell
515,970
-264,792
-34% -$994K ﹤0.01% 4667
2022
Q2 		$3.17M Sell
780,762
-67,675
-8% -$245K ﹤0.01% 4149
2022
Q1 		$3.61M Sell
848,437
-454,345
-35% -$2.58M ﹤0.01% 4029
2021
Q4 		$11.1M Buy
1,302,782
+1,043,410
+402% +$14.4M ﹤0.01% 2842
2021
Q3 		$5.29M Buy
259,372
+204,620
+374% +$4.38M ﹤0.01% 3625
2021
Q2 		$1.59M Buy
54,752
+52,647
+2,501% +$1.54M ﹤0.01% 4804
2021
Q1 		$62K Sell
2,105
-9,850
-82% -$414K ﹤0.01% 6256
2020
Q4 		$626K Buy
+11,955
New +$384K ﹤0.01% 4937

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Morgan Stanley's STTK Position: Q1 2026 in Review

Morgan Stanley increased its Shattuck Labs (STTK) stake by 1,005% in Q1 2026, buying an estimated $863K and bringing the position to 200,136 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #5019.

Morgan Stanley first reported a position in STTK in Q4 2020 and has held it in 22 quarters since. The position peaked at $11.1M in Q4 2021. 84 funds tracked by Wall St. Rank hold STTK as of Q1 2026.

  • Morgan Stanley held 200,136 shares of Shattuck Labs worth $1.29M as of Q1 2026.
  • Morgan Stanley bought 182,028 Shattuck Labs shares in Q1 2026, an estimated $863K.
  • Shattuck Labs made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #5019 holding.
  • Morgan Stanley first reported a position in Shattuck Labs in Q4 2020 and has held it in 22 quarters since.
  • Morgan Stanley's Shattuck Labs position peaked at $11.1M in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Shattuck Labs as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.